HyProCure®, a sinus tarsi stent made by GraMedica®, a global orthopedic medical device company, is gaining traction worldwide. In an article published in the most recent edition of Orthopädie & Rheuma (Orthopedic & Rheumatology), a German medical journal, Dr. Axel Schroth described the importance of stabilizing the talotarsal mechanism for the treatment of flexible flat feet and the benefits of HyProCure® over other treatment options.
Dr. Axel Schroth is an orthopedic surgeon specializing in foot and ankle surgery. Dr. Schroth practices at the Orthopaedic Specialist Center Weilheim / Garmisch-Partenkirchen / Starnberg (OFZ) in Weilheim, Bavaria, Germany. He is a member of the German Orthopaedic Foot and Ankle Society (DAF) and the German Association for Foot Surgery (GFFC).
Read full article here.
The first true talotarsal stabilization device, anatomically designed to permanently correct partial talotarsal dislocation (TTDS). If you are suffering from foot, ankle, leg, knee, or hip pain, or even flat feet, you may be experiencing the effects of Partial TaloTarsal Dislocation Syndrome (TTDS). To learn more about TTDS, visit http://www.hyprocure.com/. Find a HyProCure® trained doctor in your area at http://hyprocure.com/doctorlocator.php
No comments:
Post a Comment